[1]葛慧剑,桂思铭,邓丁伟,等.颅内未破裂动脉瘤Pipeline栓塞装置置入术后支架内狭窄的危险因素[J].中国临床神经外科杂志,2023,28(07):429-432.[doi:10.13798/j.issn.1009-153X.2023.07.004]
　GE Hui-jian,GUI Si-ming,DENG Ding-wei,et al.Risk factors for in-stent stenosis in patients with unruptured intracranial aneurysms after Pipeline embolization device implantation[J].,2023,28(07):429-432.[doi:10.13798/j.issn.1009-153X.2023.07.004]
点击复制

颅内未破裂动脉瘤Pipeline栓塞装置置入术后支架内狭窄的危险因素()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
28
期数:
2023年07期
页码:
429-432
栏目:
论著
出版日期:
2023-07-31

文章信息/Info

Title:
Risk factors for in-stent stenosis in patients with unruptured intracranial aneurysms after Pipeline embolization device implantation
文章编号:
1009-153X（2023）07-0429-04
作者:
葛慧剑; 桂思铭; 邓丁伟; 李佑祥
100070北京，首都医科大学附属北京天坛医院神经介入科（葛慧剑、李佑祥）；100070，北京市神经外科研究所（桂思铭、邓丁伟、李佑祥）
Author(s):
GE Hui-jian1;  GUI Si-ming2;  DENG Ding-wei2;  LI You-xiang1; 2
1. Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; 2. Beijing Neurosurgical Institute, Beijing 100070, China
关键词:
颅内动脉瘤; 未破裂动脉瘤; Pipeline栓塞装置; 支架内狭窄; 危险因素
Keywords:
Unruptured intracranial aneurysms;  In-stent stenosis;  Pipeline embolization device;  Risk factors
分类号:
A
DOI:
10.13798/j.issn.1009-153X.2023.07.004
文献标志码:
R743.9;R815.2
摘要:
目的 探讨颅内未破裂动脉瘤（UIA）Pipeline栓塞装置（PED）置入术后内支架狭窄（ISS）的发生率、临床预后和危险因素。方法 回顾性分析2015年9月至2020年10月接受PED治疗的460例UIA的临床资料。术后6个月复查DSA评估ISS，以PED内的管腔直径较术前缩窄超过50%定义为ISS。结果 术后中位随访时间8个月（IQR：5~16个月）。在随访过程中，66例（14.3%）出现ISS，其中17例（3.7%）出现载瘤动脉闭塞。末次随访，8例ISS有所恢复，31例为轻度ISS，10例为重度ISS，17例载瘤动脉闭塞；3例出现偏瘫，1例单侧视野缺损，1例死亡，其余61例无症状；56例（84.8%）颅内动脉瘤完全闭塞。多因素logistic回归分析显示，后循环动脉瘤（OR=2.895；95％CI 1.731~4.839；P=0.001）、球囊扩张（OR=2.380；95％CI 1.154~4.912；P=0.019）是UIA病人PED置入术后发生ISS的独立危险因素。结论 ISS是UIA病人PED置入术后常见的并发症，后循环动脉瘤和球囊扩张术治疗的病人更易发生ISS。
Abstract:
Objective To investigate the incidence, clinical prognosis and risk factors of in-stent stenosis (ISS) in patients with unruptured intracranial aneurysms (UIA) after Pipeline embolization device (PED) implantation. Methods The clinical and cerebral digital subtraction angiography (DSA) data of 460 patients with UIA who underwent PED placement from September 2015 to October 2020 were retrospectively reviewed. The DSA at 6 months after the PED implantation was used to assess the ISS, which was defined as the lumen diameter in PED was more than 50% narrower than that before the surgery. Results The median follow-up time was 8 months (IQR: 5~16 months). During the follow-up, ISS occurred in 66 patients (14.3%), of whom 17 patients (3.7%) suffered from occlusion of parent arteries. At the last follow-up, 8 patients with ISS were recovered, 31 mild ISS, 10 severe ISS, and 17 occlusion of parent arteries. Hemiplegia occurred in 3 patients, unilateral visual field defect occurred in 1 patient, and 1 patient died. Complete occlusion of aneurysms was achieved in 56 patients (84.8%) of 66 patients with ISS. Multivariate logistic regression analysis showed that posterior circulation aneurysm (OR=2.895; 95% CI 1.731~4.839; P=0.001) and balloon angioplasty (OR=2.380; 95% CI 1.154~4.912; P=0.019) were independent risk factors for ISS in UIA patients after PED implantation. Conclusions ISS is a common complication in UIA patients after PED implantation, and the patients with posterior circulation aneurysm or treated with balloon angioplasty are more prone to ISS.

参考文献/References:

[1]Kan P, Siddiqui AH, Veznedaroglu E, et al. Early postmarket results after treatment of intracranial aneurysms with the pipeline embolization device: a U.S. multicenter experience [J]. Neurosurgery, 2012, 71(6): 1080-1087.
[2]Kulcsár Z, Houdart E, Bonafé A, et al. Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment [J]. AJNR Am J Neuroradiol, 2011, 32(1): 20-25.
[3]Wang T, Richard SA, He J, et al. Institutional experience of in-stent stenosis after pipeline flow diverter implantation: a retrospective analysis of 6 isolated cases out of 118 patients [J]. Medicine (Baltimore), 2021, 100(11): e25149.
[4]Ravindran K, Salem MM, Marulanda AE, et al. Quantitative assessment of in-stent stenosis after Pipeline embolization device treatment of intracranial aneurysms: a single institution series and systematic review [J]. World Neurosurg, 2018, 120: e1031-e1040.
[5]John S, Bain MD, Hui FK, et al. Long-term follow-up of instent stenosis after Pipeline flow diversion treatment of intracranial aneurysms [J]. Neurosurgery, 2016, 78(6): 862-867.
[6]Sweid A, Starke RM, Herial N, et al. Predictors of complications, functional outcome, and morbidity in a large cohort treated with flow diversion [J]. Neurosurgery, 2020, 87(4): 730-743.
[7]Szikora I, Turányi E, Marosfoi M. Evolution of flow-diverter endothelialization and thrombus organization in giant fusiform aneurysms after flow diversion: a histopathologic study [J]. AJNR Am J Neuroradiol, 2015, 36(9): 1716-1720.
[8]Chalouhi N, Polifka A, Daou B, et al. In-Pipeline stenosis: incidence, predictors, and clinical outcomes [J]. Neurosurgery, 2015, 77(6): 875-879.
[9]Han JL, Chen JG, Tong X, et al. Morphological characteristics associated with ruptured intracranial vertebral artery dissecting aneurysms [J]. J Neurointerv Surg, 2023, 15(4): 321-324.
[10]Ge HJ, Chen XH, Liu K, et al. Endovascular treatment of large or giant basilar artery aneurysms using the Pipeline embolization device: complications and outcomes [J]. Front Neurol, 2022, 13: 843839.

相似文献/References:

[1]曾　春　张施远　蒋永明.复合手术与常规夹闭术治疗颈内动脉后交通动脉破裂动脉瘤的疗效对比研究[J].中国临床神经外科杂志,2016,(05):257.[doi:10.13798/j.issn.1009-153X.2016.05.001]
　ZENG Chun,ZHANG Shi-yuan,JIANG Yong-ming.Analysis of the effects of hybrid surgery on posterior communicating artery aneurysms: a comparison with conventional craniotomy[J].,2016,(07):257.[doi:10.13798/j.issn.1009-153X.2016.05.001]
[2]周有东　敖祥生　刘汉东　王志勇　朱耀祖　周达全.支架辅助弹簧圈和单纯弹簧圈栓塞治疗颅内动脉瘤疗效及安全性的Meta分析[J].中国临床神经外科杂志,2016,(05):274.[doi:10.13798/j.issn.1009-153X.2016.05.006]
　ZHOU You-dong,AO Xiang-sheng,LIU Han-dong,et al.A mata-analysis of curative effects of stent-assisted coiling and simple coiling on intracranial aneurysms and their safety[J].,2016,(07):274.[doi:10.13798/j.issn.1009-153X.2016.05.006]
[3]赵　平　王雄伟　汪　雷　马金阳.显微手术和血管内栓塞术治疗颅内动脉瘤的疗效分析[J].中国临床神经外科杂志,2016,(05):281.[doi:10.13798/j.issn.1009-153X.2016.05.008]
　ZHAO Ping,WANG Xiong-wei,WANG Lei,et al.Effect of endovascular treatment on intracranial aneurysms: a comparison with microsurgery[J].,2016,(07):281.[doi:10.13798/j.issn.1009-153X.2016.05.008]
[4]李朝晖　王玉贵　张孟超 综述　赵兴利 审校.CT灌注成像在动脉瘤性蛛网膜下腔出血中的 临床应用进展[J].中国临床神经外科杂志,2016,(05):313.[doi:10.13798/j.issn.1009-153X.2016.05.021]
[5]刘福德　邓剑平　张　涛　陈　虎　李　帅　王俭博　曲友直　赵振伟.椎-基底动脉夹层动脉瘤的血管内治疗（附48例分析）[J].中国临床神经外科杂志,2016,(06):353.[doi:10.13798/j.issn.1009-153X.2016.06.011]
　LIU Fu-de,DENG Jian-ping,ZHANG Tao,et al.Endovascular treatment of vertebrobasilar artery dissecting aneurysms (report of 48 cases)[J].,2016,(07):353.[doi:10.13798/j.issn.1009-153X.2016.06.011]
[6]吴有志　罗良生　张　健　陈　骅　吴　鸣　刘　振　史　岩.前循环破裂动脉瘤伴脑内血肿的 早期显微手术治疗[J].中国临床神经外科杂志,2016,(06):376.[doi:10.13798/j.issn.1009-153X.2016.06.020]
[7]潘　力　刘　鹏　秦　杰　杨　柳　安学峰　吴　虓　杨　铭　徐国政　马廉亭.Y型支架辅助技术在颅内动脉分叉部宽颈动脉瘤治疗中的应用[J].中国临床神经外科杂志,2016,(07):394.[doi:10.13798/j.issn.1009-153X.2016.07.002]
　PAN Li,LIU Peng,QIN Jie,et al.Application of Y -configuration stent technique to treatment of intracranial wide-neck bifurcation aneurysms[J].,2016,(07):394.[doi:10.13798/j.issn.1009-153X.2016.07.002]
[8]周　量　刘　丛　张昌伟.早期栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效[J].中国临床神经外科杂志,2016,(07):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
　ZHOU Liang,LIU Cong,ZHANG Chang-wei..Curative effect of early endovascular embolization on patients with ruptured intracranial aneurysms[J].,2016,(07):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
[9]张　莹　荆林凯　张倩倩　刘　健　张义森　王　坤　穆士卿　杨新健.颈内动脉后交通动脉小动脉瘤破裂危险因素分析[J].中国临床神经外科杂志,2016,(03):138.[doi:10.13798/j.issn.1009-153X.2016.03.002]
　ZHANG Ying,JING Lin-kai,ZHANG Qian-qian,et al.Analysis of risk factors related to rupture of small (diameter ≤5 mm) posterior communicating artery aneurysms[J].,2016,(07):138.[doi:10.13798/j.issn.1009-153X.2016.03.002]
[10]朱作磊 综述　罗良生 审校.动脉瘤性蛛网膜下腔出血的预后相关因素研究进展[J].中国临床神经外科杂志,2016,(03):183.[doi:10.13798/j.issn.1009-153X.2016.03.020]
[11]田　其　杨锐博　韩守孟　王军民　陈　刚　陈谦学　李明昌.Tubridge血流导向装置治疗颅内大型未破动脉瘤[J].中国临床神经外科杂志,2021,26(06):414.[doi:10.13798/j.issn.1009-153X.2021.06.004]
　TIAN Qi,YANG Rui-bo,HAN Shou-men,et al.Safety and efficacy of Tubridge flow-diverter devices for patients with large unruptured intracranial aneurysm (report of 8 cases)[J].,2021,26(07):414.[doi:10.13798/j.issn.1009-153X.2021.06.004]
[12]刘博,袁浩,尤延辉.直接暴露颈动脉穿刺栓塞治疗老年前循环未破裂动脉瘤20例[J].中国临床神经外科杂志,2022,27(01):44.[doi:10.13798/j.issn.1009-153X.2022.01.016]
[13]张翔宇,马义辉,张庭保,等.血小板聚集率检测在颅内动脉瘤介入治疗中的价值[J].中国临床神经外科杂志,2023,28(01):1.[doi:10.13798/j.issn.1009-153X.2023.01.001]
　ZHANG Xiang-yu,MA Yi-hui,ZHANG Ting-bao,et al.Value of platelet aggregation rate detection in inter-ventional treatment for patients with unruptured intra-cranial aneurysms[J].,2023,28(07):1.[doi:10.13798/j.issn.1009-153X.2023.01.001]

备注/Memo

备注/Memo:
（2023-04-25收稿，2023-06-04修回）
通讯作者：李佑祥，E-mail：liyouxiang@mail.ccmu.edu.cn
更新日期/Last Update: 2022-07-31